MYC and neoplasm: MYC overexpression induces an immunosuppressive TME through the release of chemokines, growth factors, and inflammatory cytokines, as well as promoting activation of anti-immune checkpoint proteins, such as CD47, HIF, and TRVP1, in tumor cells to suppress M1 and M2 macrophage activation [112-114].